AB Science S.A. | |
Stock Exchange | Other OTC |
EPS |
$0.78 |
Market Cap |
$206.19 M |
Shares Outstanding |
39.55 M |
Public Float |
- |
AB Science S.A. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
39.55 M |
Public Float |
- |
AB Science S.A. | |
Stock Exchange | Euronext Paris |
EPS |
EUR0.66 |
Market Cap |
EUR184.17 M |
Shares Outstanding |
40.79 M |
Public Float |
24.25 M |
Address |
3, Avenue George V Paris Ile-de-France 75008 France |
Employees | - |
Website | http://www.ab-science.com |
Updated | 07/08/2019 |
AB Science SA engages in the research, development, and sales of protein kinase inhibitor drugs. It develops pharmaceutical products for the treatment of cancer, neurological, and inflammatory diseases. The firm also engages in the field of veterinary medicine. |